US biotech unveils first allergen-free gene-edited dogs, awaits regulatory path

A US startup has developed dogs with a gene disabled to remove a major allergen, marking a first for genetically enhanced pets. The product's commercial viability hinges on regulatory approval and public acceptance, which remain uncertain. This could set a precedent for gene editing in companion animals.